Associations between cardiovascular risk, insulin resistance, β-cell function and thyroid dysfunction: A cross-sectional study in She ethnic minority group of Fujian Province in China

European Journal of Endocrinology

Volumn 163, Issue 5, 2010, Pages 775-782

  Chen, Gang ^a   Wu, Juan ^a   Lin, Yinghua ^b   Huang, Baoying ^b   Yao, Jin ^a   Jiang, Qiqin ^a   Wen, Junping ^a   Lin, Lixiang ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b Ningde Municipal Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; TRIACYLGLYCEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ANTIBODY BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CELL FUNCTION; CHINA; CHOLESTEROL BLOOD LEVEL; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; ETHNIC GROUP; ETHNICITY; EUTHYROIDISM; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HOMEOSTASIS; HUMAN; HYPERTENSION; HYPERTHYROIDISM; HYPOTHYROIDISM; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; POSTPRANDIAL STATE; PREVALENCE; PRIORITY JOURNAL; PULSE WAVE; QT INTERVAL; R WAVE; SYSTOLIC BLOOD PRESSURE; THYROTROPIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNOLOGY; MIDDLE AGED; MINORITY GROUP; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THYROID DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CHINA; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; MINORITY GROUPS; QUESTIONNAIRES; RISK FACTORS; THYROID DISEASES; YOUNG ADULT;

EID: 77957854399     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0710     Document Type: Article

References (43)

1. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T & Smith PA. The spectrum of thyroid disease in a community: the Whickham survey. Clinical Endocrinology 1977 7 481-493. (doi:10.1111/j.1365-2265.1977.tb01340.x)
2. Canaris GJ, Manowitz NR, Mayor G & Ridgway EC. The Colorado thyroid disease prevalence study. Archives of Internal Medicine 2000 160 526-534. (doi:10.1001/archinte.160.4.526)
3. O'Leary PC, Feddema PH, Michelangeli VP, Leedman PJ, Chew GT, Knuiman M, Kaye J & Walsh JP. Investigations of thyroid hormones and antibodies based on a community health survey: the Busselton thyroid study. Clinical Endocrinology 2006 64 97-104. (doi:10.1111/j.1365-2265.2005.02424.x)
4. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA & Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). Journal of Clinical Endocrinology and Metabolism 2002 87 489-499. (doi:10.1210/jc.87.2.489)
5. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA & McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Endocrine Practice 2004 10 497-501.
6. Duntas LH. Thyroid disease and lipids. Thyroid 2002 12 287-293. (doi:10.1089/10507250252949405)
7. Klein I & Danzi S. Thyroid disease and the heart. Circulation 2007 116 1725-1735. (doi:10.1161/CIRCULATIONAHA.106.678326)
8. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus, 1999.
9. Friedewald WT, Levy RI & Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/BF00280883)
11. Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, Schneiderman N, Skyler JS & Marks JB. Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Research and Clinical Practice 2000 47 177-184. (doi:10.1016/S0168-8227(99)00116-3)
12. Liberopoulos EN & Elisaf MS. Dyslipidemia in patients with thyroid disorders. Hormones 2002 1 218-223.
13. Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L & Jorgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. Journal of Clinical Endocrinology and Metabolism 2005 90 4019-4024. (doi:10.1210/jc.2004-2225)
14. Palmieri EA, Fazio S, Palmieri V, Lombardi G & Biondi B. Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of β1-adrenergic blockade. European Journal of Endocrinology 2004 150 757-762. (doi:10.1530/eje.0.1500757) (Pubitemid 38961647)
15. Nagasaki T, Inaba M, Kumeda Y, Hiura Y, Shirakawa K, Yamada S, Henmi Y, Ishimura E & Nishizawa Y. Increased pulse wave velocity in subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2006 91 154-158. (doi:10.1210/jc.2005-1342)
16. Owen PJ, Sabit R & Lazarus JH. Thyroid disease and vascular function. Thyroid 2007 17 519-524. (doi:10.1089/thy.2007.0051)
17. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT & Yan GX. T(p-e)/QT ratio as an index of arrhythmogenesis. Journal of Electrocardiology 2008 41 567-574. (doi:10.1016/j.jelectrocard.2008.07.016)
18. Verdecchia P, Angeli F, Cavallini C, Mazzotta G, Repaci S, Pede S, Borgioni C, Gentile G & Reboldi G. The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. Journal of Hypertension 2009 27 1697-1704. (doi:10.1097/HJH.0b013e32832c0031)
19. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P & Michelangeli V. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives of Internal Medicine 2005 165 2467-2472. (doi:10.1001/archinte.165.21.2467)
20. Razvi S, Weaver JU, Vanderpump MP & Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey Cohort. Journal of Clinical Endocrinology and Metabolism 2010 95 1734-1740. (doi:10.1210/jc.2009-1749)
21. Dimitriadis GD & Raptis SA. Thyroid hormone excess and glucose intolerance. Experimental and Clinical Endocrinology and Diabetes 2001 109 (Supplement 2) S225-S239. (doi:10.1055/s-2001-18584)
22. Shen DC & Davidson MB. Hyperthyroid Graves' disease causes insulin antagonism. Journal of Clinical Endocrinology and Metabolism 1985 60 1038-1041. (doi:10.1210/jcem-60-5-1038)
23. Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Koukkou E, Panagiotakos D, Tountas N, Economopoulos T & Raptis SA. Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flow. Journal of Clinical Endocrinology and Metabolism 2008 93 2413-2415. (doi:10.1210/jc.2007-2832)
24. Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Koukkou E, Tzanela M, Thalassinos N & Raptis SA. Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 2006 91 1112-1118. (doi:10.1210/jc.2005-0960) (Pubitemid 43357789)
25. Jorns A, Tiedge M & Lenzen S. Thyroxine induces pancreatic β cell apoptosis in rats. Diabetologia 2002 45 851-855. (doi:10.1007/s00125-002- 0842-5)
26. Fernandez-Mejia C & Davidson MB. Regulation of glucokinase and proinsulin gene expression and insulin secretion in RIN-m5F cells by dexamethasone, retinoic acid, and thyroid hormone. Endocrinology 1992 130 1660-1668. (doi:10.1210/en.130.3.1660)
27. Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M & Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009 373 2215-2221. (doi:10.1016/S0140-6736(09)60619-X)
28. Renauld A, Sverdlik RC & Andrade LL. Effects of hypothyroidism on serum immunoreactive insulin, free fatty acids and blood sugar in the dog as tested for oral glucose tolerance. Corrective effects of thyroxine therapy. Hormone and Metabolic Research 1974 6 137-141. (doi:10.1055/s-0028-1093878)
29. Ahren B, Lundquist I, Hedner P, Valdemarsson S & Schersten B. Glucose tolerance and insulin and C-peptide responses after various insulin secretory stimuli in hyper- and hypothyroid subjects before and after treatment. Diabetes Research 1985 2 95-103.
30. Katsilambros N, Ziegler R, Schatz H, Hinz M, Naier V & Pfeiffer EF. Intravenous glucose tolerance and insulin secretion in the rat after thyroidectomy. Hormone and Metabolic Research 1972 4 377-379. (doi:10.1055/s-0028-1094037)
31. Harris PE, Walker M, Clark F, Home PD & Alberti KG. Forearm muscle metabolism in primary hypothyroidism. European Journal of Clinical Investigation 1993 23 585-588. (doi:10.1111/j.1365-2362.1993.tb00970.x) (Pubitemid 23283068)
32. Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, Alevizaki M, Mitrou P, Lambadiari V, Boutati E, Nikzas D, Tountas N, Economopoulos T, Raptis SA & Dimitriadis G. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. European Journal of Endocrinology 2009 160 785-790. (doi:10.1530/EJE-08-0797)
33. Rochon C, Tauveron I, Dejax C, Benoit P, Capitan P, Fabricio A, Berry C, Champredon C, Thieblot P & Grizard J. Response of glucose disposal to hyperinsulinaemia in human hypothyroidism and hyperthyroidism. Clinical Science 2003 104 7-15. (doi:10.1042/CS20020154)
34. Dimitriadis G, Mitrou P, Lambadiari V, Boutati E, Maratou E, Panagiotakos DB, Koukkou E, Tzanela M, Thalassinos N & Raptis SA. Insulin action in adipose tissue and muscle in hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2006 91 4930-4937. (doi:10.1210/jc.2006-0478)
35. Tuzcu A, Bahceci M, Gokalp D, Tuzun Y & Gunes K. Subclinical hypothyroidism may be associated with elevated high-sensitive C-reactive protein (low grade inflammation) and fasting hyperinsulinemia. Endocrine Journal 2005 52 89-94. (doi:10.1507/endocrj.52.89) (Pubitemid 40410323)
36. Dessein PH, Joffe BI & Stanwix AE. Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid 2004 14 443-446. (doi:10.1089/105072504323150750)
37. Jackson IM, Prentice CR & McKiddie MT. The effect of hypothyroidism on glucose tolerance and insulin metabolism. Journal of Endocrinology 1970 47 257-258. (doi:10.1677/joe.0.0470257)
38. Fernandez-Real JM, Lopez-Bermejo A, Castro A, Casamitjana R & Ricart W. Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. Journal of Clinical Endocrinology and Metabolism 2006 91 3337-3343. (doi:10.1210/jc.2006- 0841) (Pubitemid 44402101)
39. Roos A, Bakker SJ, Links TP, Gans RO &Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. Journal of Clinical Endocrinology and Metabolism 2007 92 491-496. (doi:10.1210/jc.2006-1718) (Pubitemid 46255285)
40. Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV & Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clinical Endocrinology 2005 62 487-491. (doi:10.1111/j.1365-2265.2005.02247.x) (Pubitemid 40503377)
41. Bakker SJ, ter Maaten JC, Popp-Snijders C, Slaets JP, Heine RJ & Gans RO. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. Journal of Clinical Endocrinology and Metabolism 2001 86 1206-1211. (doi:10.1210/jc.86.3.1206)
42. Chubb SA, Davis WA & Davis TM. Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. Journal of Clinical Endocrinology and Metabolism 2005 90 5317-5320. (doi:10.1210/jc.2005-0298)
43. Utzschneider KM, Prigeon RL, Tong J, Gerchman F, Carr DB, Zraika S, Udayasankar J, Montgomery B, Mari A & Kahn SE. Within-subject variability of measures of β cell function derived from a 2 h OGTT: implications for research studies. Diabetologia 2007 50 2516-2525. (doi:10.1007/s00125-007-0819- 5) (Pubitemid 350060640)